Skip to content

13F-HR filed by Birchview Capital, LP

Birchview Capital, LP filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 72 holding rows worth $213,828,198.

Accession
0001618205-26-000003
Filed
2026-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2026

A holdings report, 73 entries on the cover page, a total value of $213,828,198 stated on the cover page (in dollars after the unit check, H1), rows summing to $213,828,198 with VALUE read as dollars as filed, 13F file number 028-16416. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
KLA CORP482480100COM178,471$53,846,485dollars as filed
Bristol-Myers Squibb Company110122108COM297,243$17,127,142dollars as filed
Lam Research Corporation512807306COM35,000$15,166,550dollars as filed
INTELLIA THERAPEUTICS INC45826J105COM385,900$6,780,968dollars as filed
SOLID BIOSCIENCES INC83422E204COMMON STOCK666,196$6,655,298dollars as filed
BIODESIX INC09075X108COM286,804$6,467,429dollars as filed
STOKE THERAPEUTICS INC86150R107COM178,110$5,827,759dollars as filed
OVINTIV INC69047Q102COM107,500$5,659,875dollars as filed
NEKTAR THERAPEUTICS640268306COMMON STOCK81,000$5,654,610dollars as filed
CORCEPT THERAPEUTICS INC218352102COM57,200$4,973,540dollars as filed
NEUROCRINE BIOSCIENCES INC64125C109COM27,190$4,582,467dollars as filed
PROTHENA CORP PLC SHSG72800108Stock449,019$4,395,896dollars as filed
ACADIA PHARMACEUTICALS INC004225108COM171,000$4,326,300dollars as filed
PROTAGONIST THERAPEUTICS74366E102COM35,018$4,292,506dollars as filed
COMPASS THERAPEUTICS INC20454B104COM1,675,000$3,668,250dollars as filed
RELMADA THERAPEUTICS INC75955J402COMMON STOCK408,100$2,824,052dollars as filed
ALKERMES PLCG01767105SHS50,000$2,619,750dollars as filed
HALOZYME THERAPEUTICS INC COM40637H109Stock33,251$2,602,556dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW69,900$2,600,979dollars as filed
CYTOKINETICS INC23282W605COM NEW30,000$2,555,700dollars as filed
OLEMA PHARMACEUTICALS INC68062P106COM199,000$2,489,490dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK57,758$2,478,396dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock4,506$2,441,486dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock93,601$2,375,593dollars as filed
UNIQURE NVN90064101SHS50,697$2,335,104dollars as filed
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock1,350,000$2,268,000dollars as filed
ABIVAX SA-00370M103SPONSORED ADS17,000$2,265,420dollars as filed
VIR BIOTECHNOLOGY INC92764N102COM220,000$2,241,800dollars as filed
BIOGEN INC COM09062X103Stock9,000$1,944,540dollars as filed
EQT CORP COM26884L109Stock34,619$1,840,692dollars as filed
BIOAGE LABS INC COM09077V100Stock69,000$1,691,190dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM29,000$1,647,490dollars as filed
QUIDEL CORP74838J101COM89,377$1,565,438dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock6,000$1,468,620dollars as filed
FOGHORN THERAPEUTICS INC344174107COMMON STOCK281,937$1,375,853dollars as filed
BICYCLE THERAPEUTICS PLC-ADR088786108SPONSORED ADS313,616$1,329,732dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY24,000$1,288,080dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock21,032$1,269,492dollars as filed
NOVO-NORDISK A S ADR670100205ADR24,000$1,150,560dollars as filed
FREEPORT MCMORAN INC CL B35671D857Stock18,035$1,134,198dollars as filed
IMMUNOME INC45257U108COM50,000$1,059,500dollars as filed
PHARVARIS NVN69605108COMMON STOCK29,847$1,032,109dollars as filed
HARROW INC415858109COM24,000$1,019,280dollars as filed
ADAGENE INC005329107CMN240,000$1,008,000dollars as filed
DEFINIUM THERAPEUTICS INC24477V105COM SHS20,000$940,800dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS71,218$781,974dollars as filed
BRIDGEBIO PHARMA INC10806X102COM8,741$651,030dollars as filed
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock48,505$645,117dollars as filed
UROGEN PHARMA LTDM96088105COMMON STOCK16,487$606,722dollars as filed
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK55,000$596,750dollars as filed
CAMP4 THERAPEUTICS CORP13463J101COM120,000$524,400dollars as filed
SAVARA INC805111101COM80,000$492,800dollars as filed
CANDEL THERAPEUTICS INC137404109COMMON STOCK47,756$491,887dollars as filed
ALTIMMUNE INC02155H200COM NEW152,681$464,150dollars as filed
COMPASS PATHWAYS PLC20451W101SPONSORED ADS30,000$424,500dollars as filed
KARYOPHARM THERAPEUTICS INC48576U106COM42,952$419,641dollars as filed
CULLINAN THERAPEUTICS INC230031106COM20,000$364,200dollars as filed
TRINITY CAP INC896442308COM20,000$357,800dollars as filed
CAPRICOR THERAPEUTICS INC14070B309COMMON STOCK14,352$345,596dollars as filed
CASTLE BIOSCIENCES INC14843C105COMMON STOCK12,984$309,668dollars as filed
INVIVYD INC00534A102COMMON STOCK342,275$298,601dollars as filed
GRACE THERAPEUTICS INC00439U104COM120,000$272,400dollars as filed
KAYNE ANDERSON BDC INC48662X105COM SHS20,000$270,600dollars as filed
VOYAGER THERAPEUTICS INC92915B106COMMON STOCK75,147$263,015dollars as filed
PULMONX CORP745848101COM200,543$260,706dollars as filed
OCULAR THERAPEUTIX INC67576A100COM20,655$202,832dollars as filed
KYNTRA BIO INC31572Q881COM NEW22,566$170,373dollars as filed
ELUTIA INC05479K106CL A COM165,094$161,726dollars as filed
QUOIN PHARMACEUTICALS LTD74907L409SPONSORED ADS20,000$96,800dollars as filed
LIPOCINE INC NEW53630X203COM NEW16,712$42,783dollars as filed
DOCGO INC256086109COM39,062$20,160dollars as filed
GOSSAMER BIO INC COM38341P102Stock18,176$2,992dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001618205-26-000003this filing2026-08-14acceptance time not in the bulk data set